Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines
- PMID: 21490181
- PMCID: PMC3084646
- DOI: 10.4065/mcp.2010.0392
Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines
Abstract
Rhinosinusitis (RS) affects approximately 1 in 7 adults in the United States, and its effect on quality of life, productivity, and finances is substantial. During the past 10 years, several expert panels from authoritative bodies have published evidence-based guidelines for the diagnosis and management of RS and its subtypes, including acute viral RS, acute bacterial RS, chronic RS (CRS) without nasal polyposis, CRS with nasal polyposis, and allergic fungal RS. This review examines and compares the recommendations of the Rhinosinusitis Initiative, the Joint Task Force on Practice Parameters, the Clinical Practice Guideline: Adult Sinusitis, the European Position Paper on Rhinosinusitis and Nasal Polyps 2007, and the British Society for Allergy and Clinical Immunology. Points of consensus and divergent opinions expressed in these guidelines regarding classification, diagnosis, and management of adults with acute RS (ARS) and CRS and their various subtypes are highlighted for the practicing clinician. Key points of agreement regarding therapy in the guidelines for ARS include the efficacy of symptomatic treatment, such as intranasal corticosteroids, and the importance of reducing the unnecessary use of antibiotics in ARS; however, guidelines do not agree precisely regarding when antibiotics should be considered as a reasonable treatment strategy. Although the guidelines diverge markedly on the management of CRS, the diagnostic utility of nasal airway examination is acknowledged by all. Important and relevant data from MEDLINE-indexed articles published since the most recent guidelines were issued are also considered, and needs for future research are discussed.
Figures
References
-
- Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. National Center for Health Statistics. Vital Health Stat 10. 2009;(242):1-157 www.cdc.gov/nchs/data/series/sr_10/sr10_242.pdf Accessed February 16, 2011 - PubMed
-
- Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Am J Rhinol Allergy. 2009;23(4):392-395 - PubMed
-
- Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113(1):104-109 - PubMed
-
- Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps Group European position paper on rhinosinusitis and nasal polyps 2007. Rhinology. 2007;45(suppl 20):1-139 http://www.ep3os.org/EPOS2007.pdf Accessed February 16, 2011 - PubMed
-
- Meltzer EO, Hamilos DL, Hadley JA, et al. American Academy of Allergy, Asthma and Immunology (AAAAI) the American Academy of Otolaryngic Allergy (AAOA) the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) the American College of Allergy, Asthma and Immunology (ACAAI) the American Rhinologic Society (ARS) Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114(6, suppl):S155-S212 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
